These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23792104)

  • 1. Adverse drug reactions induced by valproic acid.
    Nanau RM; Neuman MG
    Clin Biochem; 2013 Oct; 46(15):1323-38. PubMed ID: 23792104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid and Stevens-Johnson syndrome: a systematic review of descriptive studies.
    Rashid M; Kashyap A; Undela K
    Int J Dermatol; 2019 Sep; 58(9):1014-1022. PubMed ID: 30809807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid-induced hepatotoxicity in Alpers syndrome is associated with mitochondrial permeability transition pore opening-dependent apoptotic sensitivity in an induced pluripotent stem cell model.
    Li S; Guo J; Ying Z; Chen S; Yang L; Chen K; Long Q; Qin D; Pei D; Liu X
    Hepatology; 2015 May; 61(5):1730-9. PubMed ID: 25605636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.
    Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB
    J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced hypersensitivity syndrome caused by valproic acid as a monotherapy for epilepsy: First case report in Asian population.
    Wu XT; Hong PW; Suolang DJ; Zhou D; Stefan H
    Epilepsy Behav Case Rep; 2017; 8():108-110. PubMed ID: 29204346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic basis for idiosyncratic reactions to antiepileptic drugs.
    Franciotta D; Kwan P; Perucca E
    Curr Opin Neurol; 2009 Apr; 22(2):144-9. PubMed ID: 19262378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
    Mockenhaupt M; Messenheimer J; Tennis P; Schlingmann J
    Neurology; 2005 Apr; 64(7):1134-8. PubMed ID: 15824335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome due to concomitant use of lamotrigine and valproic acid.
    Kocak S; Girisgin SA; Gul M; Cander B; Kaya H; Kaya E
    Am J Clin Dermatol; 2007; 8(2):107-11. PubMed ID: 17428116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnitine in the treatment of valproic acid-induced toxicity.
    Lheureux PE; Hantson P
    Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.
    Sunkavalli KK; Iqbal FM; Singh B; Koneru J
    Am J Ther; 2013; 20(5):569-71. PubMed ID: 21248614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA.
    Lin CM; Thajeb P
    Metab Brain Dis; 2007 Mar; 22(1):105-9. PubMed ID: 17226098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase.
    Star K; Edwards IR; Choonara I
    PLoS One; 2014; 9(10):e108970. PubMed ID: 25302991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update.
    Guo HL; Jing X; Sun JY; Hu YH; Xu ZJ; Ni MM; Chen F; Lu XP; Qiu JC; Wang T
    Curr Pharm Des; 2019; 25(3):343-351. PubMed ID: 30931853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK; Gazioğlu S
    Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid and risperidone.
    Bertoldo M
    J Am Acad Child Adolesc Psychiatry; 2002 Jun; 41(6):632. PubMed ID: 12049437
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperammonemic encephalopathy induced by valproic acid.
    Zhu QM; Singh AK; Chang HR; Konka SA
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38350699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burst Suppression Pattern on Electroencephalogram Secondary to Valproic Acid-Induced Hyperammonemic Encephalopathy.
    Cherian KA; Legatt AD
    Pediatr Neurol; 2017 Aug; 73():88-91. PubMed ID: 28545673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome associated with concomitant use of lamotrigine and valproic acid.
    Yalçin B; Karaduman A
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):898-9. PubMed ID: 11044815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid and zonisamide induced hyperammonemic encephalopathy.
    Ilieva HS; Newman JW; Fields RK; Croom JE
    Clin Neurol Neurosurg; 2020 Sep; 196():105894. PubMed ID: 32645624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.